SCHEMBL18326152

SCHEMBL18326152

c1ccc(-c2ccc(-c3ccc(N(c4ccc(C5(c6ccccc6)c6ccccc6-c6ccccc65)cc4)c4ccc5oc6ccccc6c5c4)cc3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 2/20 0.35
OPRK1 P41145 1/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
AHR P35869 1/20 0.32
ALOX5 P09917 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
TNKS O95271 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126376 1.00 SMN1; SMN2 (0.35) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL17804767 0.98 KDM4E (0.34) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL18326153 0.97 PLA2G2A (0.36) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL16996034 0.95 KDM4E (0.33) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL16996227 0.95 KDM4E (0.33) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL17804776 0.95 PLA2G2A (0.39) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL17126433 0.95 PLA2G2A (0.39) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL24466865 0.95 MEN1 (0.39) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL19735523 0.95 KDM4E (0.32) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL23353803 0.95 KDM4E (0.32) SMN1; SMN2MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof SAMSUNG SDI CO., LTD. (KR) 2023-01-24 US disclosed
EP-3144301-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF Samsung SDI Co., Ltd. (KR) 2017-03-22 EP disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF SAMSUNG SDI CO., LTD. (KR) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160372666-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT COMPRISING SAME AND DISPLAY DEVICE THEREOF OR10J3, OR51E2, ORMDL3 SMN1; SMN2 3045/4885MEN1 958/4885KMT2A 2411/4885
US-11563179-B2 Compound, organic optoelectronic element comprising same and display device thereof OR10J3, OR51E2, ORMDL3 SMN1; SMN2 3045/4885MEN1 958/4885KMT2A 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.